{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:50:37Z","timestamp":1790398237793,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ajo.2007.09.040","type":"journal-article","created":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T07:13:23Z","timestamp":1200640403000},"page":"12-22.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Characteristics of Untreated AIDS-related Cytomegalovirus Retinitis. II. Findings in the Era of Highly Active Antiretroviral Therapy (1997 to 2000)"],"prefix":"10.1016","volume":"145","author":[{"given":"Gary N.","family":"Holland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean D.","family":"Vaudaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Shiramizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margrit","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell W.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Novack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch D.","family":"Kuppermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2007.09.040_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajo.2007.09.023","article-title":"Characteristics of untreated AIDS-related cytomegalovirus retinitis","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2007.09.040_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9394(14)70789-5","article-title":"AIDS and ophthalmology: a period of transition","volume":"124","author":"Jabs","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib4","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994\u20131997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ajo.2007.09.040_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-9394(99)00102-6","article-title":"Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy","volume":"128","author":"Doan","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(01)01322-8","article-title":"Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"133","author":"Jabs","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(96)11431-8","article-title":"Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy","volume":"349","author":"Jacobson","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2007.09.040_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1076\/ocii.7.3.179.4000","article-title":"New strategies for the management of AIDS-related CMV retinitis in the era of potent antiretroviral therapy","volume":"7","author":"Holland","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2007.09.040_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9394(99)80149-4","article-title":"Human immunodeficiency virus disease: changing patterns of intraocular inflammation","volume":"125","author":"Nussenblatt","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.293.7.817","article-title":"Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART","volume":"293","author":"Nettles","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2007.09.040_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9394(14)70784-6","article-title":"Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS","volume":"124","author":"Reed","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bjo.82.7.841f","article-title":"Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy","volume":"82","author":"Whitcup","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9394(00)00537-7","article-title":"Immune recovery uveitis","volume":"130","author":"Kuppermann","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ophtha.2005.10.067","article-title":"Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis","volume":"113","author":"Kempen","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.040_bib15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0161-6420(83)80009-8","article-title":"Acquired immune deficiency syndrome","volume":"90","author":"Holland","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.040_bib16","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2007.09.040_bib17","first-page":"141","article-title":"Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib18","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ophtha.2004.03.001","article-title":"Clinical risk factors for cytomegalovirus retinitis in patients with AIDS","volume":"111","author":"Hodge","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.040_bib19","first-page":"121","article-title":"Racial\/ethnic disparities in diagnoses of HIV\/AIDS\u201433 states, 2001\u20132004","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajo.2007.09.040_bib20","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.292.13.1612","article-title":"Measuring race and ethnicity: why and how?","volume":"292","author":"Winker","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2007.09.040_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.293.3.281","article-title":"Women shoulder growing HIV\/AIDS burden","volume":"293","author":"Voelker","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2007.09.040_bib22","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.292.21.2563","article-title":"CDC initiative targets HIV research gaps in Black and Hispanic communities","volume":"292","author":"Trubo","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2007.09.040_bib23","first-page":"1093","article-title":"Optimizing treatment for African-Americans and Latinos with HIV\/AIDS","volume":"97","author":"Butcher","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.ajo.2007.09.040_bib24","first-page":"214","article-title":"Race and the treatment of cytomegalovirus retinitis in a cohort of patients with acquired immunodeficiency syndrome","volume":"90","author":"Wutoh","year":"1998","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.ajo.2007.09.040_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archopht.121.4.466","article-title":"Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome","volume":"121","author":"Kempen","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9394(14)71453-9","article-title":"Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome","volume":"115","author":"Kuppermann","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib27","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajo.2007.09.040_bib28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/319854","article-title":"Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy","volume":"183","author":"Jacobson","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2007.09.040_bib29","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/319861","article-title":"Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen","volume":"183","author":"Piketty","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2007.09.040_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-133-6-200009190-00007","article-title":"Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy","volume":"133","author":"Grabar","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajo.2007.09.040_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00006982-200206000-00003","article-title":"Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors","volume":"22","author":"Lin","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2007.09.040_bib32","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1073\/pnas.84.23.8642","article-title":"Immediate-early gene region of human cytomegalovirus trans- activates the promoter of human immunodeficiency virus","volume":"84","author":"Davis","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajo.2007.09.040_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/infdis\/157.3.508","article-title":"Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus","volume":"157","author":"Skolnik","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2007.09.040_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel","volume":"296","author":"Hammer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2007.09.040_bib35","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_bib36","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/500210","article-title":"Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy","volume":"42","author":"Gandhi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajo.2007.09.040_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jac\/dki042","article-title":"Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven","volume":"55","author":"Lucas","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajo.2007.09.040_bib38","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ophtha.2004.05.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.040_bib39","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMp068070","article-title":"The challenge of subgroup analyses\u2014reporting without distorting","volume":"354","author":"Lagakos","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2007.09.040_bib40","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archinte.158.9.957","article-title":"Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel","volume":"158","author":"Whitley","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajo.2007.09.040_fr1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajo.2007.09.023","article-title":"Characteristics of untreated AIDS-related cytomegalovirus retinitis","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_fr2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archopht.121.1.99","article-title":"Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy","volume":"121","author":"Holbrook","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.040_fr3","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2004.05.028","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2Second eye involvement and retinal detachment","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.040_fr4","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ajo.2005.01.005","article-title":"Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis","volume":"139","author":"Kempen","year":"2005","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407009373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407009373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:55:06Z","timestamp":1757595306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939407009373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0002939407009373"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2007.09.040","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Untreated AIDS-related Cytomegalovirus Retinitis. II. Findings in the Era of Highly Active Antiretroviral Therapy (1997 to 2000)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2007.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}